A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation

Expanded access is no longer available for this treatment.

Study NCT00511771 Information provided by Novartis

First Received: August 3, 2007 Last Updated: April 10, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	Expanded access is no longer available for this treatment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given